Home / World / Archive by category Survey and Research (Page 41)

Archive by category Survey and Research

Verisk Estimates Industry Insured Losses for the Noto Peninsula Earthquake to Range from JPY 260 Billion to JPY 480 Billion (USD 1.8 Billion to 3.3 Billion)

BOSTON, Jan. 08 (Korea Bizwire) — The Extreme Event Solutions business unit of Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, estimates that insured losses to properties from the January 1 M7.5 (per the United States Geological Survey) earthquake that struck near the Noto peninsula in Ishikawa prefecture, Japan, will be between [...]

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

SAN FRANCISCO, Jan. 08, 2024 (Korea Bizwire) – Novotech, a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, announced today that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, [...]

Nasdaq European Markets Sustains Its Strong Position in the SME Listings and Sustainable Debt Mmarket in 2023

Nasdaq European Markets welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk capital and EUR 11.6 bn in secondary offerings Nasdaq celebrated its 130th company to transfer from Nasdaq First North Growth Market to Main Market STOCKHOLM, Sweden, Jan. 08, 2024 (Korea Bizwire) – Nasdaq (Nasdaq: NDAQ) today [...]

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (Korea Bizwire) – Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies’ [...]

New Research Harnesses AI and Satellite Imagery to Reveal the Expanding Footprint of Human Activity at Sea

Study reveals 75 percent of the world’s industrial fishing vessels are hidden from public view WASHINGTON, D.C., Jan. 03, 2024 (Korea Bizwire) – A new study published today in the journal Nature offers an unprecedented view of previously unmapped industrial use of the ocean and how it is changing. The groundbreaking study, led by Global Fishing Watch, uses [...]

CertiK Releases Hack3d 2023: The Web3 Security Report

NEW YORK, Jan. 03, 2024 (Korea Bizwire) – CertiK, the industry leader in blockchain security, today announced the release of its annual flagship publication. Hack3d: The Web3 Security Report for 2023 is a comprehensive report that offers an unprecedented deep dive into the security incidents, vulnerabilities, and trends that have defined the landscape of blockchain [...]

Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients

SHANGHAI, China, Jan. 02, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental new drug application (the “sNDA”) for toripalimab (trade name: TUOYI®, product code: JS001) in combination with chemotherapy [...]

New Novotech Report on Metastatic Breast Cancer Identifies 1,000 Clinical Trials Globally Since 2018

BOSTON, Dec. 30, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on Metastatic Breast Cancer. The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge. These reports offer current insights into global [...]

Early-Stage Biotech Investments Were Down 40% in 2023: Novotech Whitepaper

BOSTON, Dec. 29, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the Navigating the Biotech Landscape whitepaper examining the significant financial shifts that affected the biotech industry in 2023. DOWNLOAD THE REPORT HERE The Novotech research analyst team offers these expert whitepapers at no cost to inform planning [...]

New Novotech Report Finds 1,000 HIV Clinical Trials Globally

BOSTON, Dec. 28 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people. The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge. These [...]